SLN – silence therapeutics plc - american depository share (US:NASDAQ)
Stock Stats
News
Silence Therapeutics plc (SLN): Among the Oversold Global Stocks to Buy Right Now [Yahoo! Finance]
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $55.00 price target on the stock.
The Changing Market Dynamics of Immune Thrombocytopenia, Aplastic Anemia, and Diamond-Blackfan Anemia | DelveInsight Insights
The Changing Market Dynamics of Immune Thrombocytopenia, Aplastic Anemia, and Diamond-Blackfan Anemia | DelveInsight Insights
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Form SCHEDULE 13D/A Silence Therapeutics Filed by: Griffiths Richard Ian
Form 6-K Silence Therapeutics For: Dec 09
Form 6-K Silence Therapeutics For: Nov 18
Form SC 13G/A Silence Therapeutics Filed by: Lombard Odier Asset Management (USA) Corp
Form SC 13G/A Silence Therapeutics Filed by: Deep Track Capital, LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.